MPH Health Care AG

ETR-93M1
Deutsche Börse Xetra
Financials Asset Management
Global Rank
#25192
Country Rank
#341
Market Cap
93.01 M
Price
22.37
Change (%)
1.06%
Volume
310

MPH Health Care AG's latest marketcap:

93.01 M

As of 07/05/2025, MPH Health Care AG's market capitalization has reached $93.01 M. According to our data, MPH Health Care AG is the 25192th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 93.01 M
Revenue (ttm) 76.93 M
Net Income (ttm) 37.73 M
Shares Out 0
EPS (ttm) 8.81
Forward PE 0.00
Ex-Dividend Date 07/18/2025
Earnings Date 06/12/2025
Market Cap Chart
Data Updated: 07/05/2025

MPH Health Care AG's yearly market capitalization.

MPH Health Care AG has seen its market value drop from €102.71 M to €93.01 M since 2014, representing a total decrease of 9.44% and an annual compound decline rate (CAGR) of 0.94%.
Date Market Cap Change (%) Global Rank
07/05/2025 €93.01 M -17.41% 25192
12/30/2024 €95.9 M 36.59% 23306
12/29/2023 €70.21 M 15.49% 24785
12/30/2022 €60.8 M -31.4% 25099
12/30/2021 €88.62 M -9.21% 23064
12/30/2020 €97.62 M -41.84% 19617
12/30/2019 €167.83 M 4.67% 15084
12/28/2018 €160.34 M 0.89% 14328
12/29/2017 €158.92 M -3.56% 14828
12/30/2016 €164.79 M 74.08% 13413

Company Profile

About MPH Health Care AG

MPH Health Care AG is a German investment company specializing in the healthcare sector. Founded in 2008 and headquartered in Berlin, the company operates across multiple segments, delivering medical-aesthetic treatments, pharmaceuticals, and real estate services.

Business Segments

  • Beauty: Provides medical-aesthetic operations, treatments, and infrastructure for partner companies.
  • Pharma: Supplies pharmaceuticals and medical products in oncology, HIV/AIDS, neurology, rheumatology, chronic diseases, and aesthetic medicine.
  • Real Estate: Engages in property-related activities supporting healthcare infrastructure.

Key Offerings

  • Plastic and aesthetic treatments.
  • Development and sale of pharmaceutical and medical products.
  • Medical devices for aesthetic surgery and specialist centers.
  • Cytostatic solutions for therapeutic use.

Formerly known as MPH Mittelständische Pharma Holding AG, the company rebranded to MPH Health Care AG in 2017 to reflect its broader healthcare focus.

Frequently Asked Questions

  • What is MPH Health Care AG's (ETR-93M1) current market cap?
    As of 07/05/2025, MPH Health Care AG (including the parent company, if applicable) has an estimated market capitalization of $93.01 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • MPH Health Care AG global market capitalization ranking is approximately 25192 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.